Form 8-K - Current report:
SEC Accession No. 0000950170-25-107984
Filing Date
2025-08-13
Accepted
2025-08-13 16:01:09
Documents
11
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20250813.htm   iXBRL 8-K 52504
2 EX-99.1 cvsi-ex99_1.htm EX-99.1 591044
  Complete submission text file 0000950170-25-107984.txt   762438

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20250813.xsd EX-101.SCH 22160
14 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20250813_htm.xml XML 4003
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

EIN.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)